Cerity Partners
DNTH icon

Cerity Partners’s Dianthus Therapeutics DNTH Stock Holding History

Cerity Partners’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,250
Closed -$28K – 1496
2022
Q3 		$28K Hold
1,250
– – ﹤0.01% 1157
2022
Q2 		$24K Hold
1,250
– – ﹤0.01% 1163
2022
Q1 		$58K Hold
1,250
– – ﹤0.01% 915
2021
Q4 		$89K Hold
1,250
– – ﹤0.01% 986
2021
Q3 		$146K Sell
1,250
-375
-23% -$43.7K ﹤0.01% 662
2021
Q2 		$254K Hold
1,625
– – 0.01% 631
2021
Q1 		$308K Hold
1,625
– – 0.01% 550
2020
Q4 		$204K Hold
1,625
– – 0.01% 594
2020
Q3 		$177K Hold
1,625
– – 0.01% 473
2020
Q2 		$195K Hold
1,625
– – 0.01% 425
2020
Q1 		$163K Hold
1,625
– – 0.01% 413
2019
Q4 		$394K Buy
+1,625
New +$304K 0.02% 378

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return